Last updated 2026-06-18
- Raised funding round, Mar 2018
- Raised funding round, Jan 2017
Total raised
$6.3M
Last: 2018-03
Stage
Series A
Founded
2014
Headcount
1-10
HQ
Yavne, Israel
Sector
Health Tech & Life Sciences
About
ARTSaVIT is developing a molecular mechanism of apoptosis induced by apoptotic-related tumor suppressors (ARTS). The company's goal is to determine how the binding of ARTS to inhibitors of apoptosis proteins and other apoptotic regulators causes caspase activation and cell death. Thelab currently focuses on the molecular mechanism of ARTS-induced apoptosis, therole of ARTS as a tumor suppressor in a variety of cancer models, and the development ofin-vitro and cell-based assays for the identification and screening of small-molecule ARTS mimetics that will selectively kill cancer cells and serve as anticancer drugs. ARTSaVIT operates within the framework of Merck Ventures Israel BioIncubator.
Funding history · 2 rounds · $6.3M total
2018-03
Undisclosed
Q&A
- What is ARTSaVIT's primary focus?
- ARTSaVIT is developing a molecular mechanism of apoptosis induced by apoptotic-related tumor suppressors (ARTS), aiming to determine how ARTS binding to inhibitors of apoptosis proteins causes caspase activation and cell death.
- What is the current status of ARTSaVIT?
- ARTSaVIT is currently inactive, having ceased operations in June 2018.
- When was ARTSaVIT founded?
- ARTSaVIT was founded in February 2014.
- What is the total amount of funding ARTSaVIT raised?
- ARTSaVIT raised a total of $6,300,000.
- Which investors participated in ARTSaVIT's January 2017 funding round?
- The January 2017 funding round included Carmel-Haifa University Economic Corporation.
- Who was the investor in ARTSaVIT's March 2018 funding round?
- M Ventures invested in ARTSaVIT's March 2018 funding round.
- Who is the founder of ARTSaVIT?
- Sarit Larisch is the founder of ARTSaVIT.
Team · 1
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
Biologicals
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business model
B2B
Tags
pharmaceuticalsoncologystem-cellsbiotechnologycell-therapycancer
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | m-ventures.com/portfolio/artsavit |
|---|---|
| linkedin.com/company/28640260 |
Identifiers & details
| Former names | The Larisch Laboratory |
|---|---|
| Founded | 2014-2 |
| Status reason | Non Active, Jun 2018 ceased to operate |